Skip to main content
Log in

Schilddrüsenerkrankungen und Schwangerschaft

Thyroid Diseases and Pregnancy

  • UPDATE
  • Published:
Medizinische Klinik Aims and scope Submit manuscript

Zusammenfassung

Der Umgang mit Schilddrüsenerkrankungen während der Schwangerschaft stellt eine besondere klinische Herausforderung dar. Jede Schwangerschaft verursacht physiologische Veränderungen des Schilddrüsenhormonmetabolismus, die von pathologischen Funktionszuständen abgegrenzt werden müssen. Eine Schilddrüsenerkrankung der Mutter mit tatsächlicher Störung der Schilddrüsenfunktion kann einen nachteiligen Einfluss auf den Schwangerschaftsverlauf ausüben und negative Auswirkungen auf die Entwicklung des Fetus bedingen. Insbesondere die Hypothyreose ist während einer Schwangerschaft wegen beeinträchtigter neurokognitiver Entwicklung des Ungeborenen unter allen Umständen zu vermeiden. Auch eine mütterliche Hyperthyreose kann zur Beeinträchtigung des Schwangerschaftsverlaufs und zur fetalen Schilddrüsendysfunktion führen.

Von klinischer Bedeutung sind per se auch Autoimmunerkrankungen der Schilddrüse, da sie Ursache von Fertilitätsstörungen und einer erhöhten Rate von Spontanaborten sein können und ein erhöhtes Risiko für die Entwicklung einer Post-partum-Thyreoiditis darstellen.

Das Management von Schilddrüsenknoten einschließlich Malignität unterscheidet sich nur unwesentlich vom Vorgehen beim allgemeinen Patienten. Nuklearmedizinische Diagnostik und Therapie verbieten sich allerdings während der Schwangerschaft und ebenso in der Stillperiode.

Dieser Übersichtsartikel befasst sich mit den unterschiedlichen Facetten thyreoidaler Erkrankungen und Funktionsstörungen in und nach der Schwangerschaft. Die hier dargestellten diagnostischen und therapeutischen Vorgehensweisen basieren auf der aktuellen Clinical Practice Guideline der Endocrine Society vom August 2007.

Abstract

Thyroid diseases in pregnancy must be recognized as a specific challenge for the clinician. Any pregnancy is causing alterations in thyroid hormone metabolism which have to be differentiated from pathologic states of thyroid function. Any thyroid disease of the mother with disturbances in the functional state of the gland could induce an adverse influence on the course of pregnancy. Furthermore, it can be associated with adverse consequences on fetal development. Especially hypothyroidism has to be avoided during pregnancy due to a danger of affected neurocognitive development of the offspring. Yet also maternal hyperthyroidism can lead to impairments in the course of pregnancy and to fetal thyroid dysfunction.

Further clinical attention should be given to thyroid autoimmunity. There is a clear relationship between autoimmune thyroid disease and decreased fertility and an increase in the rate of spontaneous miscarriages. Furthermore, it displays an increased risk for the manifestation of postpartum thyroiditis.

The management of nodular thyroid disease and malignancy does not differ from that of nonpregnant women/patients. Thyroid scintiscan and radioiodine therapy must be avoided during pregnancy and lactation.

This review deals with the broad variety of thyroid disorders and function disturbances during and after pregnancy. All described diagnostic and therapeutic procedures are based upon the recent Clinical Practice Guideline of the Endocrine Society published in August 2007.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Literatur

  1. Glinoer D. Management of hypo- and hyperthyroidism during pregnancy. Growth Horm IGF Res 2003;13:Suppl A:S45–54.

    Article  PubMed  CAS  Google Scholar 

  2. Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2007;92:Suppl 8:1–47.

    Google Scholar 

  3. Klein RZ, Haddow JE, Faix JD, et al. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) 1991;35:41–6.

    Article  CAS  Google Scholar 

  4. Leung AS, Millar LK, Koonings PP, et al. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993;81:349–53.

    PubMed  CAS  Google Scholar 

  5. Wasserstrum N, Anania CA. Perinatal consequences of maternal hypothyroidism in early pregnancy and inadequate replacement. Clin Endocrinol (Oxf) 1995;42:353–8.

    Article  CAS  Google Scholar 

  6. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549–55.

    Article  PubMed  CAS  Google Scholar 

  7. Kester MH, Martinez de Mena R, Obregon MJ, et al. Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab 2004;89:3117–28.

    Article  PubMed  CAS  Google Scholar 

  8. Lazarus JH, Premawardhana LD. Screening for thyroid disease in pregnancy. J Clin Pathol 2005;58:449–52.

    Article  PubMed  CAS  Google Scholar 

  9. Stagnaro-Green A, Roman SH, Cobin RH, et al. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990;264:1422–5.

    Article  PubMed  CAS  Google Scholar 

  10. Glinoer D, Soto MF, Bourdoux P, et al. Pregnancy in patients with mild thyroid abnormalities: maternal and neonatal repercussions. J Clin Endocrinol Metab 1991;73:421–7.

    PubMed  CAS  Google Scholar 

  11. Stagnaro-Green A, Glinoer D. Thyroid autoimmunity and the risk of miscarriage. Best Pract Res Clin Endocrinol Metab 2004;18:167–81.

    Article  PubMed  CAS  Google Scholar 

  12. Negro R, Formoso G, Mangieri T, et al. Levothyroxine treatment in euthyroid pregnant women with autoimmune disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006;91:2587–91.

    Article  PubMed  CAS  Google Scholar 

  13. Poppe K, Velkeniers B, Glinoer D. Thyroid disease and female reproduction. Clin Endocrinol (Oxf) 2007;66:309–21.

    Article  CAS  Google Scholar 

  14. WHO Secretariat, Andersson M, de Benoist B, Delange F, et al. Prevention and control of iodine deficiency in pregnant and lactating women and in children less than 2-years-old: conclusions and recommendations of the Technical Consultation. Public Health Nutr 2008;10:1606–11.

    Google Scholar 

  15. Glinoer D. Clinical and biological consequences of iodine deficiency during pregnancy. Endocr Dev 2007;10:62–85.

    Article  PubMed  CAS  Google Scholar 

  16. Berbel P, Obregon MJ, Bernal J, et al. Iodine supplementation during pregnancy: a public health challenge. Trends Endocrinol Metab 2007;18:338–43.

    Article  PubMed  CAS  Google Scholar 

  17. Abalovich M, Gutierrez S, Alcaraz G, et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid 2002;12:63–8.

    Article  PubMed  CAS  Google Scholar 

  18. Alexander EK, Marqusee E, Lawrence J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004;351:241–9.

    Article  PubMed  CAS  Google Scholar 

  19. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997;18:404–33.

    Article  PubMed  CAS  Google Scholar 

  20. Rovet JF. Neurodevelopmental consequences of maternal hypothyroidism during pregnancy. Annual Meeting of the American Thyroid Association. Thyroid 2004;14:710.abstract 88.

    Google Scholar 

  21. Mestman JH. Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab 2004;18:267–88.

    Article  PubMed  CAS  Google Scholar 

  22. Millar LK, Wing DA, Leung AS, et al. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994;84:946–9.

    PubMed  CAS  Google Scholar 

  23. Verberg MF, Gillott DJ, Al-Fardan N et al. Hyperemesis gravidarum, a literature review. Hum Reprod Update 2005;11:527–39.

    Article  PubMed  CAS  Google Scholar 

  24. Goodwin TM, Montoro M, Mestman JH. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 1992;167:648–52.

    PubMed  CAS  Google Scholar 

  25. Tan JY, Loh KC, Yeo GS, et al. Transient hyperthyroidism of hyperemesis gravidarum. Br J Obstet Gynaecol 2002;109:683–8.

    Google Scholar 

  26. Rodien P, Bremont C, Sanson ML, et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 1998;339:1823–6.

    Article  PubMed  CAS  Google Scholar 

  27. Panesar NS, Li CY, Rogers MS. Reference intervals for thyroid hormones inn pregnant Chinese women. Ann Clin Biochem 2001;38:329–32.

    Article  PubMed  CAS  Google Scholar 

  28. Clementi M, Di Gianantonio E, Pelo E, et al. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet 1999;83:43–6.

    Article  PubMed  CAS  Google Scholar 

  29. Johnsson E, Larsson G, Ljunggren M. Severe malformations in infant born to hyperthyroid woman on methimazole. Lancet 1997;350:1520.

    Article  PubMed  CAS  Google Scholar 

  30. Klasco RK. REPROTOX database. Greenwood Village: Thomson Micromedex, 2005.

    Google Scholar 

  31. Hotze LA, Schumm-Draeger PA. Schilddrüsenkrankheiten - Diagnose und Therapie, 5. Aufl. Berlin: Berliner Mediznische Verlagsanstalt, 2003:124.

    Google Scholar 

  32. Momotani N, Noh JY, Ishikawa N, et al. Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves’ hyperthyroidism. J Clin Endocrinol Metab 1997;82:3633–6.

    Article  PubMed  CAS  Google Scholar 

  33. Azizi F, Hedayati M. Thyroid function in breast-fed infants whose mothers take high doses of methimazole. J Endocrinol Invest 2002;25:493–6.

    PubMed  CAS  Google Scholar 

  34. Azizi F, Khoshniat M, Bahrainian M, et al. Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 2000;85:3233–8.

    Article  PubMed  CAS  Google Scholar 

  35. Momotani N, Yamashita R, Yoshimoto M, et al. Recovery from fetal hypothyroidism: evidence for the safety of breast-feeding while taking propylthiouracil. Clin Endocrinol (Oxf) 1989;31:591–5.

    Article  CAS  Google Scholar 

  36. American Academy of Pediatrics Committee on Drugs. Transfer of drugs and other chemicals into human milk. Pediatrics 2001;108:776–89.

    Google Scholar 

  37. Amino N, Tanizawa O, Mori H, et al. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves’ disease. J Clin Endocrinol Metab 1982;55:108–12.

    Article  PubMed  CAS  Google Scholar 

  38. Weetman AP. Graves’ disease. N Engl J Med 2000;343:1236–48.

    Article  PubMed  CAS  Google Scholar 

  39. Luton D, Le Gac I, Vuillard E, et al. Management of Graves’ disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 2005;90:6093–8.

    Article  PubMed  CAS  Google Scholar 

  40. Casey BM, Dashe JS, Wells CE, et al. Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006;107:337–41.

    PubMed  Google Scholar 

  41. Amino N, Tada H, Hidaka Y. Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid 1999;9:705–13.

    Article  PubMed  CAS  Google Scholar 

  42. Stagnaro-Green A. Postpartum thyroiditis. Best Pract Res Clin Endocrinol Metab 2004;18:303–16.

    Article  PubMed  CAS  Google Scholar 

  43. Negro R, Greco G, Mangieri T, et al. The influence of selenium supplementation on postpartum thyroid status in pregnant women with thyroid peroxidase autoantibodies. J Clin Endocrinol Metab 2007;92:1263–8.

    Article  PubMed  CAS  Google Scholar 

  44. Tachi J, Amino N, Tamaki H, et al. Long term follow-up and HLA association in patients with postpartum hypothyroidism. J Clin Endocrinol Metab 1988;66:480–4.

    PubMed  CAS  Google Scholar 

  45. Karger S, Tötsch M, Krause K, et al. Der Schilddrüsenknoten - Differentialdiagnostik und Therapiekonzepte. Med Klin 2008;103:575–88.

    Article  Google Scholar 

  46. Sam S, Molitch ME. Timing and special concerns regarding endocrine surgery during pregnancy. Endocrinol Metab Clin North Am 2003;32:337–54.

    Article  PubMed  Google Scholar 

  47. Doherty CM, Shindo ML, Rice DH, et al. Management of thyroid nodules during pregnancy. Laryngoscope 1995;105:251–5.

    Article  PubMed  CAS  Google Scholar 

  48. Moosa M, Mazzaferri EL. Outcome of differentiated thyroid cancer diagnosed in pregnant women. J Clin Endocrinol Metab 1997;82:2862–6.

    Article  PubMed  CAS  Google Scholar 

  49. Schlumberger M, De Vathaire F, Ceccarelli C, et al. Outcome of pregnancy in women with thyroid carcinoma. J Endocrinol Invest 1995;18:150–1.

    PubMed  CAS  Google Scholar 

  50. Cooper DS, Doherty GM, Haugen BR, et al. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2006;16:109–42.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dagmar Führer-Sakel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karger, S., Führer-Sakel, D. Schilddrüsenerkrankungen und Schwangerschaft. Med Klin 104, 450–456 (2009). https://doi.org/10.1007/s00063-009-1094-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00063-009-1094-7

Schlüsselwörter:

Key Words:

Navigation